Article
Differential Role of NKG2A/Hla-E Interaction in the Outcome of Bladder Cancer Patients Treated with M. bovis Bcg or Other Therapies
2024-11-18
Abstract excerpt
<h4>Background: </h4> Immunotherapy is gaining great relevance both in non-muscle invasive bladder cancer (NMIBC) with the use of bacille Calmette-Guerin (BCG), and in muscle invasive BC (MIBC) with anti-checkpoint therapies blocking PD-1/PD-L1, CTLA-4/CD80-CD86 and more recently NKG2A/HLA-E interactions. Biomarkers to optimize the use of these therapies are necessary. <h4>Methods:</h4> Killer-cell immunoglobulin-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- a96a02f5-c7ca-5241-92da-bb32e1ee5c48
- DOI
- 10.20944/preprints202411.1269.v1
